Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
FDA approve new drug to treat high cholesterol
Repatha is the second in a class of drugs to be approved by the FDA that addresses how the liver performs in relation to the treatment of high cholesterol.
TiGenix announces Cx601 meets primary endpoint in pivotal Phase III trial
TiGenix NV, an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, has announced that...
Pivotal global Phase III study data for Fycompa® (perampanel) in primary generalised tonic-clonic seizures now published in Neurology
Pivotal, global phase III study results for Fycompa® (perampanel) in primary generalised tonic-clonic (PGTC) seizures are published for the first time today in Neurology.
Drug leads to significant weight loss for people with type 2 diabetes
Researchers find a daily dose of the diabetes drug liraglutide may lead to substantial weight loss for people with type 2 diabetes who are overweight or obese.
'Female Viagra' approved by FDA
The FDA have approved the first ever drug to treat low sexual desire in premenopausal women. Flibanserin - brand name Addyi - will be available from mid-October.
Phase 3 results for investigational therapy ITCA 650 in type 2 diabetes
Intarcia Therapeutics, Inc. has announced positive top-line results from its 52-week Phase 3 FREEDOM-2 clinical trial to determine the comparative efficacy of the company's late-stage...
Moffitt Cancer Center seeks breast cancer survivors for genetic counseling study
Moffitt Cancer Center is looking for breast cancer survivors for a study evaluating the effectiveness of new educational materials about genetic counseling.
Results from B-YOND extension study reinforce long-term clinical profile of ALPROLIX for the treatment of hemophilia B
New clinical data support the long-term safety and efficacy of ALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in people with severe hemophilia B treated for up to two years...
Antidepressant drug trials criteria not generalizable
Most patients are likely to be excluded from participating in treatment studiesMark Zimmerman, M.D.
Coca-Cola and the problem with industry-funded research
In light of the news that Coca-Cola is funding an organization claiming that lack of exercise is the primary cause of obesity, we investigate the role of industry-funded research.
Argos Therapeutics announces pilot clinical trial of AGS-003 as neoadjuvant immunotherapy for localized renal cell carcinoma
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis®...
Patient-funded trials may do more harm than good, ethicists warn
In the era of launching Kickstarter campaigns to pay for just about anything, Carnegie Mellon University ethicists warn that the trend of patients funding their own clinical trials may do more harm...
New medical research reporting requirements may lead to fewer positive outcomes
The adoption of new transparent reporting standards may have contributed to a significant reduction in the percentage of studies reporting positive research findings among large-budget clinical...
Stroke therapy put to the test in preclinical randomized controlled trial
In the midst of what some call a "crisis" in the ability to replicate results of laboratory studies, a European consortium has conducted a preclinical randomized controlled trial (pRCT), which mimics...
A new way to kill melanoma skin cancers
Scientists are adding new DNA to the cells of patients in a world-first treatment to attack and kill melanoma skin cancers.
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2015
Content Management / Website Design by Tresware